Harmonic Discovery is developing new therapeutic drugs that embrace the complexity of diseases. The current paradigm of drug discovery involves identifying drugs that target a single biological mechanism. Harmonic on the other hand are creating a new generation of therapeutics that can disrupt multiple pathways by targeting the human kinome. The kinome includes a family of 500 proteins associated with diseases such as cancer, autoimmunity and neurodegeneration. To find therapeutics, Harmonic is using their platform that integrates multiple layers of information from 3D-protein structure to systemic changes in protein gene expression using medicinal chemistry and machine learning.

<p>Claim company profile to add description to this page.</p>


Harmonic Discovery

Founded: 2021
Location: New York, NY
Employee range: 1 - 10
Clinical stage: RD
Product link: https://www.harmonicdiscovery.com/science
Funding: $8M seed Sep 2022
Investors: Innovation endeavors, Fifty Years, Y Combinator, Boom Capital, Caffeinated Capital

Short description:

Drug notes:

Long description:

Jobs: